{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Puma Biotechnology Inc"},"Symbol":{"label":"Symbol","value":"PBYI"},"Address":{"label":"Address","value":"10880 WILSHIRE BOULEVARD,SUITE 2150, LOS ANGELES, California, 90024, United States"},"Phone":{"label":"Phone","value":"+1 424 248-6500"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357."},"CompanyUrl":{"label":"Company Url","value":"http://www.pumabiotechnology.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Alan H. Auerbach","title":"Chairman, President & Chief Executive Officer"},{"name":"Alvin F. Wong","title":"Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}